logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

New Quinolones With Potential Antimrsa Activity 1st Edition Saeed Emami

  • SKU: BELL-51357012
New Quinolones With Potential Antimrsa Activity 1st Edition Saeed Emami
$ 31.00 $ 45.00 (-31%)

4.8

14 reviews

New Quinolones With Potential Antimrsa Activity 1st Edition Saeed Emami instant download after payment.

Publisher: Nova Science Publishers, Incorporated
File Extension: PDF
File size: 1.97 MB
Pages: 126
Author: Saeed Emami
ISBN: 9781614703686, 161470368X
Language: English
Year: 2010
Edition: 1

Product desciption

New Quinolones With Potential Antimrsa Activity 1st Edition Saeed Emami by Saeed Emami 9781614703686, 161470368X instant download after payment.

Quinolone antibacterial agents are among the most attractive drugs in the field of anti-infective chemotherapy. Quinolones target the essential bacterial type II topoisomerases, which are involved in DNA replication and metabolism. Despite a large number of quinolones approved for the treatment of bacterial infections, there have been progressive efforts for the discovery of new quinolones to overcome the problem of growing bacterial resistance. This book discusses the structural requirements of quinolones for anti-MRSA activity and introduce the newly developed quinolones to manage MRSA infections, their in-vitro effectiveness based on recent studies and structure-activity relationships.

Related Products